In addition to the regulation of GOT1 by KRAS, oncogenic PIK3CA mutations also have been reported to mediate metabolic reprograming of glutamine in colorectal cancer (CRC) by upregulating glutamate pyruvate transaminase 2 (GPT2) (58). Here, GPT2 is linked to colorectal carcinoma.